Financials disclosed in this offering
No financial statements linked to this round
The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.
Deal terms
Estimated, not stated: $2.0292 × 26,322,589 securities outstanding as of Dec 31, 2020 (Form C-AR filed May 4, 2022, p. 6).
Down round. Priced 26% below ASTRALABS Stock 2 (Jan 2021): $2.0292 vs $2.75 a share in today's terms.
Offering details
Links & provenance
Last synced Sep 23, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.